Fremont, CA, United States of America

Upinder Singh


Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 33(Granted Patents)


Company Filing History:

goldMedal1 out of 832,680 
Other
 patents

Years Active: 2003

Loading Chart...
1 patent (USPTO):

Title: Upinder Singh - Innovator in Telomerase Inhibition

Introduction

Upinder Singh is a notable inventor based in Fremont, CA, who has made significant contributions to the field of biotechnology. His work primarily focuses on telomerase inhibitors, which have important implications in the treatment of various diseases, including cancer. With one patent to his name, Singh's innovations are paving the way for new therapeutic approaches.

Latest Patents

Singh's patent, titled "Telomerase inhibitors and methods of their use," encompasses thiazolidinedione compounds, compositions, and methods aimed at inhibiting telomerase activity. This patent outlines the use of these compounds both in vitro and in vivo for treating conditions mediated by telomerase activity. The invention also includes novel methods for assaying or screening for inhibitors of telomerase activity, which could be crucial in cancer treatment.

Career Highlights

Throughout his career, Upinder Singh has demonstrated a commitment to advancing medical science through innovative research. His focus on telomerase inhibitors showcases his dedication to finding effective treatments for serious health conditions. Singh's work is characterized by a blend of scientific rigor and practical application, making his contributions valuable to the medical community.

Collaborations

Singh has collaborated with talented individuals such as Allison C. Chin and Ryan Holcomb. These partnerships highlight the collaborative nature of scientific research, where diverse expertise can lead to groundbreaking discoveries.

Conclusion

Upinder Singh's work in telomerase inhibition represents a significant advancement in the field of biotechnology. His innovative approaches and dedication to research are likely to have a lasting impact on the treatment of diseases mediated by telomerase activity.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…